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Abstract 
Master Thesis, Programme in Medicine 
Title: Associations between self-reported dietary intake in randomly selected men and women 
in relation to the metabolic syndrome and the individual components of the syndrome. 
Eric Ljungkvist, 2015, Institute of Medicine,  
Sahlgrenska Academy, University of Gothenburg, Sweden 
Introduction: The metabolic syndrome (MetS) is a collection of five medical conditions: 
central obesity, increased triglycerides, reduced HDL-cholesterol, hypertension and increased 
fasting plasma glucose. The components of the MetS cover a subset of known cardiovascular 
risk factors. Several additional adverse health effects are associated with the MetS for 
instance increased risk to develop type 2 diabetes, Alzheimer disease and cancer. A vast body 
of scientific research have earlier investigated the relationship between diet and the MetS; but 
the conclusions are still inconsistent. 
Aim: To investigate the impact of self-reported dietary intake, in a randomly selected 
population of men and women, on the MetS and individual components of the syndrome. 
Methods: A cross-sectional population-based study, of randomly selected adult men and 
women, was used to analyse the associations between self-reported dietary intake and the 
MetS and individual components of the syndrome.  
Results: In men sugar (mono- and disaccharides) intake was significantly positively 
associated with the MetS. The strongest associations included sugar intake being negatively 
associated with HDL-cholesterol in men. In women total carbohydrate intake was negatively 
associated with HDL-cholesterol and fasting blood glucose. In men polyunsaturated fatty 
acids was negatively associated with systolic and diastolic blood pressure. 
Conclusion: In men, simple carbohydrates, was positively associated with the MetS. Simple 
and total carbohydrates were negatively associated with HDL-cholesterol in men and women, 
respectively. Polyunsaturated fatty acids were negatively associated with both systolic and 
diastolic blood pressure. The results from this cross-sectional study are in concordance with 
present dietary recommendations to prevent common disease risk factors: to limit sugar intake 
and to increase intake of polyunsaturated fatty acids. The difference, in influence of diet on 
the MetS, between sexes is intriguing and demand further research on whether men and 
women are affected differently in various diet composition. 
Key words: metabolic syndrome, dietary intake, randomly selected sample, cross-sectional 
study.  
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Introduction 
The metabolic syndrome 
The metabolic syndrome (MetS) is a collection of five medical conditions: central obesity, 
increased triglycerides, reduced HDL-cholesterol (HDL-C), hypertension and increased 
fasting plasma glucose (Table 1). An individual with three or more of these components is 
considered having the MetS. In a consensus statement, from the International Diabetes 
Federation (IDF) (1), on the MetS, published in 2006 (updated as a joint scientific statement 
in 2009 (2)), the IDF state that obesity plays a crucial role in the increasing prevalence of the 
MetS. The components of the MetS cover a subset of known cardiovascular risk factors. 
Presence of the MetS has been associated with increased risk for coronary heart disease 
(CHD)(3, 4). Several observational studies have suggested an increased risk of cardiovascular 
disease (CVD) and cardiovascular as well as all-cause mortality in persons with the MetS (5-
8). In addition to predict risk, CVD-studies have suggested that individuals with the MetS has 
as much as a five-fold risk of developing type 2 diabetes (T2DM) (4, 9) and it has been 
suggested that the greatest benefit of the MetS is to use it as a risk-estimate of T2DM (10). All 
studies are not solely positive and criticism has been raised against the clinical relevance of 
the MetS. Existing competing algorithms to estimate risk of CVD and T2DM i.e. Framingham 
Risk Score (11) and Diabetes Risk Score (12) are suggested to be superior. 
Yet, the list of adverse effects associated with the MetS is still growing and spans from 
chronic kidney disease, non-alcoholic fatty liver disease (NAFLD), Alzheimer disease, cancer 
and worsening of health-related quality of life (13-17). 
The IDF acknowledge that there are many unanswered questions related to the MetS, one of 
the greater questions being the aetiology of the MetS. 
Diet and the metabolic syndrome  
Historically overweight and obesity have been argued to be the most important risk factors for 
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the MetS. The prevalence and incidence of T2DM, dyslipidaemia and CVD increase with 
increasing BMI, but there is heterogeneity in presence of illness, between individuals with 
similar BMI values. It has been suggested that more than 20% of normal-weight individuals 
are metabolically unhealthy, while more than 30% of obese adults are metabolically healthy 
(18). This has led researchers to the conclusion that obesity rather being a marker of 
metabolic dysfunction in contrast of being its cause (19). An obvious question that comes 
with all diseases closely related to an unhealthy metabolism is what impact various dietary 
nutrients have on the disease? Exploring dietary nutrients in relation to disease is an appealing 
thought, but does at the same time present great challenges. Rigorous scientific research 
providing causal evidence (i.e. randomised controlled trials, RCTs) is expensive and requires 
extensive periods of time which makes these studies hard to fund and implement in great 
scale. Observational studies are easier to accomplish with sufficient material and time but do 
not provide causal inference. 
The MetS is closely related to insulin resistance; in fact The Insulin resistance syndrome is 
one of several earlier names the MetS has been referred to as (1). In a study by Samaha et al. a 
carbohydrate-restricted (<30 grams/day) diet was shown to increase insulin sensitivity and 
glycaemic control in 132 severely obese subjects with high prevalence of T2DM and the 
MetS (20). This effect remained even after adjustment was made for the weight loss achieved. 
Other potential effects of a carbohydrate-restricted diet are illustrated in a study by Volek et 
al. where 12 healthy normal-weight men demonstrated a significant decrease of 34% in serum 
insulin concentration after six weeks on a carbohydrate-restricted (8 percent of energy intake, 
E%) diet (21). 
It is an intriguing thought that a carbohydrate-restricted diet would reduce the postprandial 
glucose level and insulin response and thereby be advantageous for improving components of 
the MetS, with the greatest effects seen in triglyceride and HDL-C levels suggestively (22). 
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This has also been suggested through observational studies where a high carbohydrate intake 
was associated with adverse effects on the components of the MetS (23-25). 
Several RCTs, ranging from six weeks to two years follow-up, have tested the hypothesis that 
restricting total carbohydrate intake compared to restricting total fat intake will have a 
beneficial outcome regarding the MetS variables (20, 26-32), especially in lowering 
triglyceride concentration and increasing HDL-C concentration. Other studies have not shown 
any differences regarding the impact of altering the macronutrient composition on the MetS 
(33, 34), some rather recognizing the weight loss achieved by any diet as the most important 
positive influence on the MetS. Further aspects have been added to the discussion whether the 
definition of a carbohydrate-restricted diet is congruently defined between studies (35). In a 
Cochrane report published in 2007 the authors suggest that a diet with a low glycaemic index 
(LGI) or load has favourable effects concerning the lipid profile compared to a diet with a 
higher glycaemic index (HGI) or load. This fact might propose the quality of the 
carbohydrates consumed is more important than the total carbohydrate intake. With this in 
mind a LGI diet might be paralleled by a decrease in total carbohydrate intake (36), but not 
always. 
In respect of the discussion regarding weight loss and the MetS, one aspect of diet and weight 
loss in relation to metabolic risk factors is shown by Krauss et al. (37). In an interpretation of 
the study by Krauss et al., Feinman and Volek suggest that there was a significant 
improvement in metabolic profile on a carbohydrate-restricted diet when compared to a low-
fat (LF) diet, even in the absence of weight loss. On a LF diet, improvement in metabolic 
profile was only seen when accompanied with weight reduction (38). 
The Swedish Council on Health Technology Assessment (SBU) (22) note in their systematic 
comparison on dietary advice for obese individuals that a low carbohydrate diet compared to a 
low fat diet results in increased HDL cholesterol without negative effects on LDL cholesterol, 
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at least during the first six months of intervention. The effect was seen in both a moderate low 
carbohydrate diet (carbohydrate intake <40E% ) as well as a very low carbohydrate diet (<20 
E%). The very low carbohydrate diet also indicated improved glucose values in the short term 
along with reduced triglycerides (22). 
These findings raise intriguing questions regarding the associations between habitual 
carbohydrate intake and metabolic risk factors in randomly selected adult men and women. 
Aim 
The aim of this study is to examine the impact of energy and macronutrient intake on 
components of the MetS and the MetS as such, in randomly selected men and women. 
Subjects and Methods 
Study population  
The study population was the reference group to the Swedish Obese Subjects (SOS) study 
(39). The Swedish Obese Subjects reference study (40) included a total of 1135 subjects, 524 
men and 611 women, 37-61 years of age. The participants were randomly selected, from a 
population registry, living in the cities of Mölndal and Örebro, Sweden. The examinations 
were performed between August 1994 and December 1999. The participation rates were 
53.7% for men and 57.6% for women (40). 
Habitual food intake  
A, 51 questions, semi-quantitative dietary questionnaire on habitual food and beverage intake 
during the last 3 months was completed by the subjects.  
The questionnaire was developed within the SOS study. To validate the dietary questionnaire 
Lindroos et al. (41) carried out a study including 45 obese and 19 non-obese subjects, aged 
21-61 years. The validation process of the questionnaire included a 4-day food registration 
were the subjects kept food records for four consecutive days, after filling out the dietary 
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questionnaire. An open-circuit indirect calorimetry system was used to determine the subjects 
basic metabolic rate (BMR), the calculation included oxygen consumption, carbon dioxide 
production and urinary nitrogen excretion. The 24h energy expenditure (24EE) was estimated 
based on each individuals BMR along with self-reported physical activity. The 24EE was 
later compared with the calculated energy intake from the diet records and the questionnaire. 
Mean energy intake from the dietary questionnaire in comparison with the 24EE proposed a 
5% (non-significant) discrepancy in normal weight individuals and a 4% non-significant 
difference in the obese (41). The authors concluded that the use of the dietary questionnaire 
for recording energy intake was as valid in the obese as in normal weight individuals. 
Looking at selected nutrients (e.g. protein, total carbohydrate and total fat) the nutrient 
estimates from the questionnaire were all significantly correlated compared to the food 
records, when adjustment was made for total energy intake (41). 
Statistical methods 
Initially, to visualise the basic characteristics of the study population, Student’s t-test was 
used to compare the population according to gender. Prevalence of the MetS was also 
calculated. Values are presented as means (s.d.) if not stated otherwise. Dietary variables (e.g. 
carbohydrate, fat and protein) where analysed as continuous absolute variables (grams) as 
well as relative measures, E%. Due to statistical reasons and because of the simpler 
representation of data continuous absolute variables are presented throughout the study. Men 
and women were analysed separately throughout the study. To explore correlation between 
continuous dietary variables and components of the MetS, Pearson’s correlation was used. 
Self-reported dietary data is accompanied with a non-negligible amount of uncertainty due to 
recall bias. One way to deal with this fact is to categorize continuous variables into ordinals 
(i.e. comparing groups with increasing intake of a specific dietary nutrient). Hence dividing 
the study subjects into quartiles in respect of dietary nutrients was used in this study. When 
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expecting great measurement error of the dietary variables one way to increase the contrast 
between the groups of “lowest” and “highest” intake of a specific macronutrient, is to pool 
quartiles into “tertiles” (i.e. low intake equals 1st quartile, medium intake equals 2nd plus 3rd 
quartile, high intake equals 4
th
 quartile). Consequently three groups where formed for each 
individual macronutrient. Throughout the report these groups are referred to as quartiles. To 
examine correlation between quartiles and the MetS variables rank correlation (Spearman’s 
correlation) was used. This procedure is customary when analysing correlation for ordinal 
data. To illustrate the correlation between continuous macronutrients as well as quartiles and 
variables of the MetS scatterplots as well as boxplots were drawn. To utilize the statistically 
reinforced contrast between 1
st
 quartile (low intake) and 4
th
 quartile (high intake) Student’s t-
test was performed to compare means of the variables of the MetS according to various 
dietary data. Further analyses included bivariate and multivariate linear regression to examine 
the impact of dietary factors on the individual MetS variables. In order to visualise the 
correlation between macronutrient quartiles (absolute measure, g/day) and prevalence of the 
MetS, crosstabs and Chi
2
-test were performed.  To further investigate any potential 
correlation between macronutrients and prevalence of the MetS, logistic multivariate 
regression was performed. During both linear and logistic regression adjustment was made for 
age, BMI, physical activity (during leisure time) and total energy intake (kcal/day). 
Analyses were performed with SPSS Statistics Version 22 for Windows. 
Ethics 
As expressed by Larsson et al. (40), “the ethical committee of Göteborg University approved 
the protocol and informed consent was obtained from all subjects before the examinations.” 
Results 
The clinical criteria specifying the MetS are described in Table 1. 
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Table 2 displays descriptive characteristics of the study population. Data are presented for the 
total group as well as for men and women, respectively. The population was comprised of 
46.2% men and 53.8% women. Men and women were of similar age, while men had a 
statistically significant higher BMI, blood pressure and self-reported total energy intake 
compared to women. In relative terms men reported lower E% carbohydrate intake but higher 
E% fat intake than women (Table 2). A statistically significant higher prevalence of the MetS 
was found in men compared to women (Table 2). 
Table 4 (a and b) displays rank correlation coefficients between macronutrient quartiles and 
the variables of the MetS. Table 5 (a and b) displays the comparison of means of the variables 
of the MetS between the 1
st
 quartile (low intake) and 4
th
 quartile (high intake) according to 
various macronutrients. To increase the readability and simplifying presentation of the results 
of this study the results (Table 6a, 6b, 7a and 7b) from analysing macronutrients (continuous) 
and their correlation with the components of the MetS, are presented in the appendix. These 
results are depictured and described in the report but results from analysing quartiles (Table 
4a, 4b, 5a and 5b) are stressed. Table 6 (a and b, appendix) displays Pearson’s correlation 
coefficients between macronutrients and each of the variables of the MetS while Table 7 (a 
and b, appendix) demonstrate linear multivariate regression of macronutrients and variables of 
the MetS. 
Figures 1 through 3 visualise the strongest rank correlation coefficients (r<-0.120) as 
presented in Table 4b. Figures 4 through 7 (appendix) visualise the strongest Pearson’s 
correlation coefficients (r<-0.120, r>0.120) as presented in Table 6a and 6b (appendix). 
Carbohydrate intake 
In men, those with the highest sugar (mono- and disaccharides are referred to as sugar 
throughout the entire report) intake (4
th
 quartile) also had significantly higher prevalence of 
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the MetS compared with lower intakes (p=0.032). No such association was found among 
women (Table 3). In men, prevalence of the MetS in the 1
st
 quartile (low intake) was 19.2%, 
in 2
nd
 plus 3
rd
 quartiles (medium intake) 18.2% and in the 4
th
 quartile (high intake) 29.6%. No 
other self-reported macronutrient intake in either sex was significantly associated with the 
prevalence of the MetS. In women, carbohydrate intake indicated a trend toward significant 
association with prevalence of the MetS (p=0.067), not shown. 
In women, carbohydrate intake was negatively associated with HDL-C and fasting glucose, 
using rank correlation (Table 4a) and comparing means of 1
st
 and 4
th
 quartile (Table 5a). In 
men, sugar intake was negatively associated with HDL-C (Table 4b). Comparing means of 1
st
 
and 4
th
 quartile in men, sugar intake was positively associated with triglyceride level and 
negatively associated with HDL-C (Table 5b). Pearson correlation (Table 6a, appendix), 
showed that total carbohydrate intake was positively associated with triglyceride level and 
negatively associated with HDL-C, in men. In women, total carbohydrate intake was 
negatively associated with fasting blood glucose using Pearson correlation (Table 6a, 
appendix). Analysing sugar intake showed a positive association with BMI and triglyceride 
level along with a negative association with HDL-C, in men (Table 6b, appendix). Total fibre 
intake was positively associated with triglycerides, in men (Table 6 b, appendix). 
In men, employing linear regression on the data at hand, the results were concordant in the 
negative correlation between carbohydrate intake and HDL-C. Carbohydrate (p=0.002, Table 
7a, appendix) and sugar (p=0.018, Table 7b, appendix) intake was negatively associated with 
waist circumference, in men. Sugar intake also showed a negative association with HDL-C, in 
men (Table 7b, appendix). Dietary fibre was positively associated with triglycerides in men 
(Table 7b, appendix). However, residual plots rejected the results because the triglyceride 
variable did not meet the criteria of normal distribution. This fact was true for all results that 
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included triglycerides in the linear multivariate regression analysis (Table 7a and 7b, 
appendix). 
Fat intake 
When quartiles of total fat intake were examined with rank correlation, a negative association 
with systolic blood pressure (SBP) was found, in men. In women, total fat intake was 
negatively associated with diastolic blood pressure (DBP) (Table 4a). When quartiles of 
subgroups of fat intake were analysed poly-unsaturated fatty acids (PUFA) were negatively 
associated with SBP and DBP, in men. In women, PUFA were negatively associated with 
HDL-cholesterol and DBP (Table 4b). In women, mono-unsaturated fatty acids (MUFA) were 
negatively associated with DBP in women using rank correlation (Table 4b). Total fat intake 
was negatively associated with DBP, in women, when means of 1
st
 and 4
th
 quartiles were 
compared (Table 5a). PUFA were negatively associated with SBP and DBP in men (Table 
5b). In women, PUFA were negatively associated with HDL-C and DBP (Table 5b). MUFA 
intake presented a negative correlation with DBP when means of 1
st
 and 4
th
 quartiles were 
compared (Table 5b). PUFA also displayed a negative correlation with HDL-C (Table 5b). 
Total fat intake (continuous) was negatively associated with both SBP and DBP in men 
(Table 6a, appendix). When subgroups of fat were analysed the Pearson’s correlations 
remained and were strengthened for PUFA, in men. PUFA were also negatively associated 
with HDL-cholesterol in women. MUFA exhibited a negative association with SBP along 
with a positive association with triglycerides, in men. In women, MUFA were negatively 
associated with DBP (Table 6b, appendix).  
Dividing fat intake into subgroups, linear multivariate regression did strengthen the results of 
PUFA being negatively associated with both DBP and SBP, in men. PUFA also showed a 
weak positive association with waist circumference, in men (Table 7b, appendix). 
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Protein intake 
Protein intake was negatively associated with HDL-C in women (Table 5a). 
In women, linear multivariate regression showed a negative association between protein 
intake and triglycerides (Table 7a, appendix). 
Total energy intake 
In women, total energy intake was negatively associated with HDL-C using rank correlation 
(Table 4a). This was also true when comparing means of 1
st
 and 4
th
 quartiles, in women 
(Table 5b). 
Total energy intake was positively associated with triglycerides, in men, using Pearson 
correlation (p<0.05) (Table 6a, appendix). This correlation did not remain with rank 
correlation (p=0.967) (Table 4a). 
Total energy intake was positively associated with triglycerides, in men, but did not fulfil the 
criteria of normally distributed residuals as stated earlier (Table 7b, appendix). 
Discussion 
In this study on a randomly selected population of adult middle-aged men and women, self-
reported energy and macronutrient intake was analysed in relation to the prevalence of the 
metabolic syndrome as well as the separate components included in the criteria of the 
syndrome. Utilizing the contrast of analysing lowest and highest quartiles of various dietary 
variables and focusing on the strongest correlations the main results of this study are, in men, 
self-reported sugar intake was positively associated with triglyceride level and negatively 
associated with HDL-C. In women total carbohydrate intake was negatively associated with 
HDL-C and fasting B-glucose. In men, PUFA was negatively associated with DBP and SBP. 
In women, total fat, MUFA and PUFA were negatively associated with DBP. PUFA also 
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showed a negative association with HDL-C. In women, protein intake and total energy intake 
displayed a negative association with HDL-C. 
Carbohydrate intake in general was negatively associated with HDL-C in women; in men this 
association was true for sugar intake. In men, sugar intake was also positively associated with 
triglyceride level. These associations are in resemblance with earlier studies performed with 
other research designs (27, 32, 42). 
In women, carbohydrate intake was negatively associated with fasting B-glucose; these results 
are somewhat surprising, as one would expect a positive association between carbohydrate 
intake and glucose level. This might reflect the well-known fact that some foods are 
notoriously underreported. More specifically, often underreported foods are those that are 
commonly known that one should not eat, for example, sweets, chocolate, cookies, buns and 
ice-cream, all with high carbohydrate content. Underreporting of the mentioned kinds of 
foods might lead to the paradoxical association seen in this study because the underreporting 
may be greater in those consuming the highest quantity of these foods, compared with groups 
with less frequent consumption of these foods. In this study no associations between sugar 
intake and components of the MetS were seen in women (as opposed to men), this along with 
the known fact that women more frequently underreport dietary intake compared to men (43) 
might explain these differences. 
The negative association between total fat intake and blood pressure might reflect the impact 
MUFA and PUFA have on blood pressure. Indeed the negative associations in this study 
strengthened when PUFA alone was analysed in relation to blood pressure. PUFA or more 
specifically fish oil (predominantly eicosapentaenoic (EPA) and docosahexaenoic acid 
(DHA)) has been found to lower blood pressure levels as well as decreasing the risk of 
coronary death and total mortality (44, 45). The blood pressure lowering effect is evidently 
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more pronounced in older and hypertensive subjects (44). Hypertension is a major risk factor 
for cardiovascular events so the results of this study could be considered in line with previous 
scientific research. The negative association between MUFA and DBP in women is to some 
extent consistent with the scientific literature. A Mediterranean diet rich in olive oil (MUFA) 
has been argued to have a potential role in lowering blood pressure (46). Saturated fatty acids 
(SFA) presented no association with adverse metabolic outcomes in the current study; this is 
also in accordance with earlier studies. Several meta-analyses have previously shown SFA 
neutral to all-cause mortality, CVD, total CHD, fatal CHD, ischaemic stroke and T2DM (47-
50). To identify deleterious effects from dietary nutrients on health, a long time period of 
observation is needed. This is provided by observational studies, which in turn only provide 
associations. Randomised controlled clinical trials are needed to provide causal evidence of 
the obtained associations. With RCTs much of the discussion concerning the results are 
whether differences of the study population is of importance (e.g. primary or secondary 
prevention). This is indeed an area of scientific research of much controversy. It has been 
proposed changing SFA for PUFA is beneficial from a cardiovascular health perspective but 
this is still debated (42, 51). 
In women, protein intake was negatively associated with HDL-C, at least when analysing 
quartiles of protein intake (Table 5a). This finding contradicts earlier studies were subjects 
consuming a high-protein diet either maintains higher circulating levels of, or shows an 
improvement in, HDL-C (31, 52). The fact that this association was not seen with rank 
correlation (Table 4a) weakens this association. 
Total energy intake was negatively associated with HDL-C in women (Table 4a). 
Epidemiological studies have previously shown that an increase in total carbohydrate intake 
was paralleled with an increase in total energy intake; this covariance might account for the 
present association (53). The rank correlation was significant though in the lower range, in 
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this study correlations approximate to +/-0.1, and greater, was considered being of interest; 
which in this case weaken these results. 
It has been proposed that total carbohydrate intake per se should not be considered in 
association with the MetS but rather subgroups i.e. glucose and fructose (19, 54, 55). In the 
current study information about sugar (mono- and disaccharides i.e. glucose, fructose, 
galactose, sucrose and lactose were analysed together in this study) intake was available but 
individual subgroups were not. Access to the data about specific subgroups of macronutrients 
would potentially strengthen the associations of this study and make it possible to further 
investigate the relationship between habitual food intake and the MetS. 
Methodological considerations 
In this study, men and women were analysed separately with respect to the MetS and energy 
and macronutrients. This approach can be discussed. Analysing men and women collectively 
would result in a greater number of measure points in one group and would broaden the range 
of data points for the various dietary variables. With a larger set of data one could expect 
correlations to strengthen which would be preferable. With respect to this the approach 
chosen has its advantages. First off the clinical criteria of the MetS do distinguish between 
men and women on two measures (Table 1); waist circumference and HDL-C, which have 
sex-dependant cut-off limits. This makes analyses of correlation between each individual 
component of the MetS and dietary variables harder to interpret. Men and women do 
differentiate to a greater or lesser extent in respect of habitual dietary intake on all 
macronutrients analysed (Table 2). This fact makes the analysis of quartiles of dietary 
variables and variables of the MetS less straight forward if men and women were to be 
analysed as a single group. 
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Analysing various dietary factors impact on health related variables is indeed a difficult task 
to take on. One could argue about which is the better way to present and analyse intake of 
different macronutrients. In this study presenting macronutrients as absolute continuous 
variables, in contrast to percent of total energy intake, was chosen. The fact that absolute 
measures are easier to visualise and calculations are easier to perform affected this decision. 
When performing multivariate regression the question of co-variation between a specific 
macronutrient and total energy intake has to be considered. Analysing a macronutrient and 
adjusting for total energy intake, which are not independent variables, can be discussed. 
Willet et al. have in earlier studies argued these adjustments can still be made (56). 
Due to the great incertitude of self-reported dietary data correlations often exhibit low Pearson 
and Spearman correlation coefficients. A Pearson or Spearman correlation coefficient 
approximate to +/-0.1, or greater, was in this study considered being of interest. 
Limitations 
The data set used in this study does not contain any information about medication that might 
impact variables of the MetS. The most commonly used drugs targeting dyslipidaemias are 
statins, their main actions are considered lowering LDL-cholesterol and total cholesterol, 
which are not part of the MetS (57). Therefore omitting information on the use of statins in 
this study might not impact the results to a great extent. Alternative medications that could 
alternate variables of the MetS are fibrates and nicotinic acid. These are the most commonly 
used drugs that reduce triglycerides and raise HDL-C. The use of high dose Omega-3 fatty 
acids does impact triglycerides hence this information would contribute to the study (2). 
Furthermore there is no available information on antihypertensive drug treatment, in patients 
with previous hypertension, which is an alternative to fulfilling the criteria of hypertension of 
the MetS. Since antihypertensive drug treatment is rather frequent in the population this data 
would most certainly influence the prevalence of the MetS. An alternative indicator of the 
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elevated fasting glucose-criteria is drug treatment of elevated glucose; the same reasoning 
goes for these drugs.  
Simultaneous disease could indeed affect the MetS. Patients with T2DM will commonly fulfil 
the criteria of the MetS, naturally omitting all drug treatments used for these diseases will 
underestimate the prevalence. 
Smoking is a known cardio metabolic risk factor and available smoking status should 
preferably have been controlled for when performing various types of regression. The fact 
that there was no available information on the individual level regarding smoking is a great 
weakness of this study. Intake and use of alcohol is also a potential metabolic risk factor, thus 
in an optimal estimation of the impact of self-reported dietary intake on the MetS, this should 
have been taken into account. Information about alcohol intake was registered in the SOS 
reference study (40) but was not used in the analyses of this study due to statistical reasons. 
This is another limitation of this study. 
In the SOS reference study (40) participants and non-participants were compared in respect of 
smoking habits. Only non-participants from the Mölndal part of the study 1994-1996 were 
examined, through telephone interview. Non-participants were significantly more often 
smokers and less often ex-smokers compared with participants. This fact may underestimate 
the impact smoking has on the cardio metabolic risk and the prevalence of the MetS in the 
general population. 
Participants and non-participants did not significantly differ in respect of medication nor the 
prevalence of disease, which consolidate the possibility of extrapolating the results to the 
general population. 
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In this study there was no information about the ethnicity of the participants. In the current 
definition of the MetS different cut-points of waist circumference are based on ethnicity. This 
may or may not influence the outcome of this study.  
Furthermore, the validity of the dietary questionnaire might be questioned when used in the 
present study. In the validation process normal weight and obese individuals were compared. 
In the present study men and women are compared and overweight individuals are also 
included in the randomly selected study group, which were not included in the validation 
process. It has been proposed that women generally have a greater level of underreporting 
dietary intake compared to men (43).  In the validating study selected nutrients were 
overestimated 5-35% using the questionnaire compared to the food records. The between 
method correlation was at its lowest for mono + disaccharides (r=0.33) and r=0.43 for total 
carbohydrate intake (41). Recall bias is important to consider when using retrospective 
questionnaires on dietary patterns. All methods measuring habitual food intake are prone to 
mis- or underreporting. The incertitude of this study is in comparison with similar studies 
(43). 
There are a variety of food-frequency questionnaires (FFQs) being used when analysing 
dietary variables in relation to disease. Since validation of the FFQ is a complicated process, 
and the fact that there is no gold standard in validating the questionnaire, this does add a great 
deal of incertitude to the self-reported habitual food intake. In the present case the FFQ was 
designed specifically for the SOS Study that gives the advantage of the authors being able to 
detail the requirements of the FFQ, trying to answer the questions asked. The FFQ was 
originally designed to answer questions about habitual food intake in relation to obesity. In 
this study the information collected was used to explore the association between habitual food 
intake and the MetS; a question which the FFQ was not initially designed to answer. This 
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might be a weakness of the present study, but the close covariation between obesity and the 
MetS might imply this is not a great issue. 
The use of epidemiological studies when analysing habitual food intake in relation to disease 
does indeed come with weaknesses. At first, from a cross-sectional study only associations 
can be determined and causal inference cannot be made. RCTs focusing on individual 
nutrients, outlined by observational evidence, often fail to demonstrate the hypothesised effect 
(58). The use of dietary patterns can still be proven useful in the search of any influence of 
habitual food intake in relation to disease, and is still important in the process of establishing 
new hypotheses. 
Marks et al. suggest that gender is one of the personal characteristics that are most strongly 
associated with estimate errors when reporting food intake, using FFQs (59). Agreement 
between reported and actual intake also varies to a great extent between food groups, 
vegetables being one of the groups with the poorest consistency. This implies that separation 
according to gender might be preferred before analysing the data, as practised in this study. 
On the other hand different FFQs used depending on gender might be a better way to make 
use of this proposition. 
The FFQ used is in this study requested the study subjects to answer questions about a variety 
of food groups. The purpose of the study was to examine the effect of a variety of 
macronutrients on the MetS. A preferable approach when analysing single macronutrients is 
to present study subjects with a comprehensive food list (43). This is a weakness of the usage 
of the current FFQ. One way of increasing the certainty of the analyses would be to analyse 
individual food groups instead of macronutrients and their impact on the MetS. Individual 
food groups have previously been associated with the MetS e.g. sugar-sweetened beverages 
which Malik et al. address in a meta-analysis (60). From the current study one could obtain 
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associations that later must be tested in more rigorous ways i.e. RCTs to eventually express 
ideas of causality. 
The participation rate of the study was 53.7% for men and 57.6% for women. The great non-
participation rate is a considerable weakness of the study. Making statements of the general 
population from the results of the study might not be advisable in this case. 
Definitions of the metabolic syndrome  
Today the IDF consensus statement is considered the most revised definition of MetS. 
Previous to the current report, valid definitions include the World Health Organization 
(WHO)(61), which has been considered the general definition. Parallel with the WHO 
definition further definitions include The European Group for the Study of Insulin Resistance 
(EGIR)(62) which is a modified version of the WHO definitions, both published in 1999. In 
2001 a definition more suited for clinical practice was published in the Journal of the 
American Medical Association, the National Cholesterol Education Program – Third Adult 
Treatment Panel (NCEP ATP III)(63). The 2002 American Association of Clinical 
Endocrinology Position Statement (AACE)(64) has also been used as a clinical guideline. All 
definitions and statements share basic parts i.e. obesity, insulin resistance, dyslipidaemia and 
hypertension, but differ regarding some criteria and cut-off values. The need for a compact, 
clinically accessible and scientifically valid definition was identified by the IDF and their 
statement was published in 2006 and updated in 2009.  
The prevalence of the MetS increases with age and the fact that different studies build on 
different definitions of the MetS a coherent figure is sometimes hard to define. In Sweden, the 
prevalence of the MetS has been appreciated to range from 18.8 - 21.9% depending on the 
definition (65). Using the IDF definition results in a higher prevalence (21.9%) in comparison 
with previous definitions. Despite this fact the IDF definition did not have a preferable 
22 
 
prediction rate, compared to earlier definitions, regarding cardiovascular events. A coincident 
study on 60-year-old men and women in Stockholm reported an incidence of the MetS being 
24% and 19% for men and women respectively (66). In the H70 study carried out in 
Gothenburg the 70-year-old cohort found an overall prevalence of the MetS of 22.6% (26.3% 
in men and 19.2% in women) (67). Due to the fact that different MetS-definitions are used, it 
is hard to compare studies regarding prevalence of the MetS. Several components have impact 
on the prevalence of the MetS, a collection of which includes lifestyle, genetic factors and age 
that further complicates the comparison between studies (68). The fact that the MetS varies 
between ethnic groups has led to the introduction of region-specific cut-points regarding waist 
circumference in the IDF-definition. Using NHANES data Aguilar et al. (69) report that the 
prevalence of the MetS has remained stable around 35% since 2007, at least in an North 
American population. 
Hence the use of different definitions of the MetS does influence prevalence and is important 
to keep in mind when comparing different studies. 
Conclusions and implications 
The results of this study are largely consistent with earlier scientific research. The lack of 
consensus in the interpretation of the scientific literature requires more rigorous scientific 
research to be undertaken. An important concern of this study is the great incertitude of self-
reported dietary intake. Diagnose and an efficient way of treating the MetS would have great 
health benefits for the general population since the prevalence of the MetS is high. According 
to this study and the current scientific literature in general, a diet restricted, preferentially in 
simple carbohydrates and favourable fat quality, have a role in the treatment of the MetS and 
may reduce the risk of the components of the syndrome.  
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Populärvetenskaplig sammanfattning 
Titel: Association mellan självrapporterat kostintag och det metabola syndromet och de 
ingående variablerna i syndromet, hos slumpmässigt utvalda män och kvinnor.  
Examensarbete 30 HP, Läkarprogrammet 
Eric Ljungkvist, 2015, Institutionen för Medicin,  
Sahlgrenska akademin, Göteborgs universitet 
Sammanfattning: Det metabola syndromet är en samling av fem medicinska tillstånd: 
bukfetma, påverkade blodfetter (förhöjda triglycerider, lågt HDL-kolesterol (det ”goda” 
kolesterolet)), högt blodtryck samt förhöjt fasteblodsocker. En individ som uppfyller 
kriterierna för det metabola syndromet har bland annat ökad risk för att utveckla 
hjärtkärlsjukdom, typ 2 diabetes, Alzheimers sjukdom och cancer. Kostens koppling till det 
metabola syndromet har upprepade gånger undersökts i vetenskapliga studier. Detta till trots 
råder det ingen enighet angående kostrekommendationer för någon som uppfyller kriterierna 
för det metabola syndromet. I denna studie har kopplingen mellan kostintag som 
studiedeltagare själva rapporterat och det metabola syndromet undersökts, hos slumpmässigt 
utvalda män och kvinnor. Mellan 1994 och 1999 samlades information om kostintag in 
genom att slumpmässigt utvalda män och kvinnor i Mölndal och Örebro fick svara på enkäter 
angående sina kostvanor. Blodprover och övriga prover mättes vid ett tillfälle. Koppling 
mellan det rapporterade kostintaget och kriterierna för det metabola syndromet har sedan 
statistiskt analyserats. 
Resultat i den här studien inkluderar: intag av enkla sockerarter (mono- och disackarider, t.ex. 
bordssocker, fruktsocker och mjölksocker) var kopplat till ökad förekomst av metabola 
syndromet hos män. De starkaste kopplingarna mellan kostintag och enskilda mätvärden i det 
metabola syndromet i den här studien var en koppling mellan sockerintag och lägre blodfett 
(HDL-kolesterol) hos män. Hos kvinnor var totalt kolhydratintag kopplat till lägre blodfett 
(HDL-kolesterol) och lägre fasteblodsocker. Hos män var intag av fleromättade fetter kopplat 
till lägre blodtryck. 
Hos män var enkla sockerarter kopplat till ökad risk att ha metabola syndromet. Intag av enkla 
sockerarter och totalt kolhydratintag var kopplat till en lägre nivå av blodfett (HDL-
kolesterol) hos både män och kvinnor. Fleromättade fetter var kopplat till lägre blodtryck 
(systoliskt och diastoliskt). Resultaten från den här tvärsnittsstudien stämmer till stor del 
överens med de nuvarande kostrekommendationerna för att motverka vanliga riskfaktorer för 
ämnesomsättningssjukdom: att minska intag av socker och ett ökat intag av fleromättade 
fetter. Skillnaden mellan könen är intressant och det krävs ytterligare forskning för att utröna 
om män och kvinnor påverkas olika av olika kostsammansättning.  
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Figures and tables 
 
Table 1. Clinical criteria of the metabolic syndrome. 
Measure Cut-off points 
Waist circumference (cm) Males ≥ 94, Females ≥ 80 
S-Triglycerides (mmol/l)
1
 ≥ 1.7 
S-HDL-cholesterol(mmol/l)
1
 Males <1.0, Females < 1.3 
Blood pressure (mmHg)
2
 SBP ≥ 130 and/or DBP ≥85 
Fasting P-glucose (mmol/l)
3
 ≥ 5.6 
HDL: high-density lipoprotein, SBP: systolic blood pressure, DBP: diastolic blood pressure, P: 
plasma. 
1
drug treatment used for elevated triglycerides or reduced HDL-C is also used as an indicator. 
2
drug treatment for previously diagnosed hypertension is also used as an indicator. 
3
drug treatment for elevated plasma glucose is also used as an indicator. 
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Table 2. Descriptive characteristics of the study population. 
  
 
Total Males Females P-value* 
 
n=1135 n=524 n=611 
 Age (years) 49.5(7.0) 49.8(7.0) 49.3(7.0) 0.226 
BMI (kg/m
2
) 25.2(3.8) 25.9(3.4) 24.7(4.1) <0.001 
MetS variables 
    Waist circumference (cm) 87.9(11.2) 92.6(9.8) 83.8(10.8) <0.001 
Systolic blood pressure (mmHg) 125.2(19.1) 128.5(19.0) 122.3(18.6) <0.001 
Diastolic blood pressure (mmHg) 76.6(11.3) 79.2(11.2) 74.5(11.0) <0.001 
S-Triglycerides (mmol/l) 1.32(0.79) 1.52(0.91) 1.13(0.62) <0.001 
S-HDL-cholesterol (mmol/l) 1.45(0.40) 1.28(0.33) 1.60(0.41) <0.001 
Fasting B-glucose (mmol/l)  4.4(0.9) 4.5(1.0) 4.3(1.0) <0.001 
Dietary variables 
    Total energy (kcal/day) 2473.9(834.0) 2777.0(865.9) 2219.7(713.7) <0.001 
Carbohydrate (E%) 45.6(5.4) 44.8(5.3) 46.3(5.4) <0.001 
Fat (E%) 35.5(4.8) 35.9(4.7) 35.2(4.7) 0.012 
Protein (E%) 15.5(2.1) 15.1(2.0) 15.7(2.1) <0.001 
Carbohydrate (g/day) 281(99) 310(102) 257(89) <0.001 
Fat (g/day) 99(40) 112(42) 87(33) <0.001 
Protein (g/day) 95(32) 104(33) 87(28) <0.001 
Sugar
1
 (g/day) 118(58) 127(62) 110(54) <0.001 
Fibre (g/day) 22(8) 23(8) 22(7) 0.007 
MUFA (g/day) 32(13) 37(14) 29(11) <0.001 
PUFA (g/day) 14(6) 16(6) 12(5) <0.001 
SFA (g/day) 42(19) 48(20) 37(16) <0.001 
MetS prevalence (n,%) 197(17.4) 111(21.2) 86(14.1) 0.002 
HDL: high-density lipoprotein, E%: percent of total energy intake, kcal: kilocalories, MetS: metabolic syndrome, 
MUFA: mono-unsaturated fatty acids, PUFA: poly-unsaturated fatty acids, SFA: saturated fatty acids, B: blood. 
Values expressed as mean (s.d.), except MetS prevalence n (%). 
  * Independent samples t-test comparing sex, p<0.05 is considered significant. 
 1mono- and disaccharides analysed.  
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Table 3. Crosstabs sugar
1
 quartiles and MetS prevalence. 
 Males Quartile 1 Quartile 2-3 Quartile 4 p -value* 
MetS prevalence 19.20% 18.20% 29.60% 0.032 
     Females Quartile 1 Quartile 2-3 Quartile 4 p -value* 
MetS prevalence 16.20% 11.70% 16.70% 0.252 
*Pearson Chi
2
 
    Quartile 1: low intake (<84g), Quartile 2-3: medium intake (84-153g), Quartile 4: high intake (>153g), MetS: 
metabolic syndrome. 
Calculations performed on sugar quartiles (g/day). 
1
mono- and disaccharides analysed. 
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Table 4a. Correlation coefficients for the association between quartiles of 
macronutrient intake and MetS variables. 
 Males CHO Fat Protein Kcal 
BMI (kg/m
2
) -0.018 -0.055 0.02 -0.037 
Waist circumference (cm) -0.027 -0.007 0.042 -0.005 
S-Triglycerides (mmol/l) -0.016 -0.029 -0.054 -0.002 
S-HDL-cholesterol (mmol/l) -0.066 -0.042 -0.015 -0.021 
Systolic blood pressure (mmHg) -0.045 -0.090* -0.079 -0.064 
Diastolic blood pressure (mmHg) -0.062 -0.08 -0.055 -0.061 
Fasting B-glucose (mmol/l) -0.025 -0.017 -0.038 -0.026 
Females CHO Fat Protein Kcal 
BMI (kg/m
2
) -0.045 -0.078 -0.019 -0.027 
Waist circumference (cm) 0.016 0.009 0.056 0.058 
S-Triglycerides (mmol/l) 0.042 -0.034 0 0.017 
S-HDL-cholesterol (mmol/l) -0.096* -0.055 -0.08 -0.081* 
Systolic blood pressure (mmHg) -0.003 -0.035 0.005 0.029 
Diastolic blood pressure (mmHg) -0.067 -0.090* -0.046 -0.044 
Fasting B-glucose (mmol/l) -0.099* -0.063 -0.056 -0.08 
HDL: high-density lipoprotein, MetS: metabolic syndrome, CHO: carbohydrates, Kcal: 
kilocalories, B: blood. 
Calculations performed on macronutrient quartiles (g/day) and total energy intake 
(kcal/day). 
All correlations expressed as rank correlation (Spearman's rho, rs). 
 * Correlation is significant at the 0.05 level. 
   ** Correlation is significant at the 0.01 level. 
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Table 4b. Correlation coefficients for the association between quartiles of sugar, dietary fibre, 
mono-unsaturated fatty acid, poly-unsaturated fatty acid, saturated fatty acid intake and MetS 
variables. 
 Males Sugar
1
 Fibre MUFA PUFA SFA 
BMI (kg/m
2
) 0.082 -0.02 -0.041 -0.071 -0.061 
Waist circumference (cm) 0.071 -0.023 -0.01 -0.029 -0.044 
S-Triglycerides (mmol/l) 0.06 0.01 0.005 -0.01 -0.031 
S-HDL-cholesterol (mmol/l) -0.145** -0.023 -0.025 -0.009 -0.029 
Systolic blood pressure (mmHg) 0.009 -0.03 -0.083 -0.127** -0.081 
Diastolic blood pressure (mmHg) -0.032 -0.044 -0.075 -0.131** -0.056 
Fasting B-glucose (mmol/l) -0.015 -0.023 -0.013 0 0.004 
Females Sugar
1
 Fibre MUFA PUFA SFA 
BMI (kg/m
2
) -0.031 0.01 -0.068 -0.052 -0.072 
Waist circumference (cm) 0.024 0.053 0.016 0.016 -0.002 
S-Triglycerides (mmol/l) 0.044 0.063 -0.048 -0.016 -0.011 
S-HDL-cholesterol (mmol/l) -0.062 -0.028 -0.066 -0.085* -0.064 
Systolic blood pressure (mmHg) 0.071 0 -0.051 -0.063 0.025 
Diastolic blood pressure (mmHg) -0.011 -0.048 -0.096* -0.090* -0.03 
Fasting B-glucose (mmol/l) -0.048 -0.042 -0.06 -0.073 -0.063 
HDL: high-density lipoprotein, MetS: metabolic syndrome, MUFA: mono-unsaturated fatty acids, PUFA: poly-
unsaturated fatty acids, SFA: saturated fatty acids, B: blood. 
Calculations performed on macronutrient quartiles (g/day). 
   All correlations expressed as rank correlation (Spearman's rho, rs). 
  * Correlation is significant at the 0.05 level. 
    ** Correlation is significant at the 0.01 level. 
    1mono- and disaccharides analysed.     
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Table 5a. Student's t-test quartiles of macronutrient intake and MetS variables. 
    Males CHO 
  
Fat 
  
Protein 
  
 
Q1 Q4 p Q1 Q4 p Q1 Q4 p 
BMI (kg/m
2
) 26.2(3.5) 26.0(3.7) 0.695 26.3(3.5) 25.8(3.4) 0.185 26.1(3.6) 26.2(3.4) 0.942 
Waist circ. (cm) 93.8(10.0) 92.7(10.4) 0.39 93.6(9.5) 93.0(9.7) 0.64 93.1(10.1) 93.6(9.8) 0.694 
S-TG (mmol/l) 1.51(0.79) 1.56(1.01) 0.654 1.60(0.92) 1.61(1.05) 0.904 1.58(0.85) 1.57(1.05) 0.91 
S-HDL-C (mmol/l) 1.29(0.29) 1.23(0.30) 0.092 1.27(0.28) 1.24(0.30) 0.375 1.27(0.30) 1.25(0.31) 0.626 
SBP (mmHg) 130(20) 128(19) 0.289 130(19) 126(19) 0.08 130(19) 127(19) 0.155 
DBP (mmHg) 80(11) 78(12) 0.186 80(11) 78(13) 0.168 80(11) 78(11) 0.15 
FG (mmol/l) 4.54(0.87) 4.48(0.76) 0.606 4.54(0.78) 4.51(0.75) 0.745 4.52(0.77) 4.50(0.86) 0.822 
Females CHO 
  
Fat 
  
Protein 
  
 
Q1 Q4 p Q1 Q4 p Q1 Q4 p 
BMI (kg/m
2
) 24.8(4.0) 24.6(4.7) 0.594 25.2(3.8) 24.9(5.1) 0.598 24.7(3.8) 25.0(5.1) 0.566 
Waist circ. (cm) 83.5(10.4) 84.0(11.9) 0.702 84.0(9.8) 84.9(12.6) 0.473 82.6(10.4) 84.7(12.1) 0.128 
S-TG (mmol/l) 1.12(0.58) 1.21(0.70) 0.217 1.16(0.58) 1.16(0.68) 0.965 1.11(0.52) 1.14(0.59) 0.581 
S-HDL-C (mmol/l) 1.68 (0.43) 1.56 (0.41) 0.02 1.63(0.46) 1.56(0.40) 0.162 1.66 (0.46) 1.56 (0.39) 0.043 
SBP (mmHg) 124(20) 123(17) 0.64 124(19) 122(18) 0.464 122(18) 123(17) 0.98 
DBP (mmHg) 76(12) 74(11) 0.124 76 (11) 73 (11) 0.04 75(11) 74(9.7) 0.179 
FG (mmol/l) 4.39 (0.77) 4.18 (0.56) 0.011 4.39(1.11) 4.30(1.19) 0.496 4.31(0.66) 4.28(1.15) 0.785 
TG: triglycerides, HDL: high-density lipoprotein, MetS: metabolic syndrome, CHO: carbohydrates, SBP: systolic blood 
pressure, DBP: diastolic blood pressure, FG: fasting blood glucose, Q: quartile. 
Calculations performed on macronutrient quartiles (g/day). 
     Values expressed as mean (s.d.). 
       p-values <0.05 is considered significant. 
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Table 5b. Student's t-test quartiles of sugar, dietary fibre, mono-unsaturated fatty acid, poly-unsaturated 
fatty acid, saturated fatty acid intake and MetS variables. 
  Males Kcal 
  
Sugar
1
 
  
Fibre 
  
 
Q1 Q4 p Q1 Q4 p Q1 Q4 p 
BMI (kg/m
2
) 26.3(3.4) 26.0(3.7) 0.493 25.7(3.5) 26.5(3.7) 0.093 26.0(3.6) 25.8(3.3) 0.537 
Waist circ. (cm) 93.6(9.8) 93.1(10.4) 0.719 92.6(9.7) 94.1(10.1) 0.239 93.6(10.1) 92.7(9.3) 0.444 
S-TG (mmol/l) 1.52(0.79) 1.63(1.07) 0.346 1.49(0.78) 1.75(1.15) 0.039 1.52(0.85) 1.65(1.11) 0.274 
S-HDL-C (mmol/l) 1.28(0.29) 1.26(0.30) 0.559 1.31(0.30) 1.18(0.29) <0.001 1.27(0.31) 1.25(0.33) 0.616 
SBP (mmHg) 130(19) 127(19) 0.2 128(20) 128(17) 0.786 130(20) 128(19) 0.418 
DBP (mmHg) 80(11) 78(12) 0.22 79(11) 78(11) 0.542 80(12) 78(11) 0.173 
FG (mmol/l) 4.52(0.76) 4.49(0.76) 0.815 4.55(0.88) 4.48(0.67) 0.493 4.50(0.77) 4.47(0.74) 0.733 
Females Kcal 
  
Sugar
1
 
  
Fibre 
  
 
Q1 Q4 p Q1 Q4 p Q1 Q4 p 
BMI (kg/m
2
) 24.9(3.9) 25.0(5.0) 0.815 25.0(4.1) 24.8(4.6) 0.628 24.7(4.0) 25.0(4.5) 0.613 
Waist circ. (cm) 83.1(9.9) 85.2(12.5) 0.112 83.9(10.7) 84.5(11.8) 0.658 83.8(10.7) 85.3(10.9) 0.238 
S-TG (mmol/l) 1.12(0.56) 1.19(0.68) 0.363 1.14(0.61) 1.22(0.68) 0.284 1.13(0.58) 1.22(0.62) 0.173 
S-HDL-C (mmol/l) 1.65(0.44) 1.54(0.39) 0.037 1.64(0.44) 1.57(0.42) 0.136 1.63(0.41) 1.59(0.37) 0.42 
SBP (mmHg) 122(18) 123(18) 0.509 122(20) 125(18) 0.177 123(20) 122(18) 0.76 
DBP (mmHg) 75(11) 74(10) 0.265 75(12) 74(11) 0.675 76(12) 74(10) 0.212 
FG (mmol/l) 4.40(0.80) 4.32(1.17) 0.469 4.37(0.78) 4.29(1.04) 0.442 4.41(1.13) 4.31(1.16) 0.482 
Males MUFA 
  
PUFA 
  
SFA 
  
 
Q1 Q4 p Q1 Q4 p Q1 Q4 p 
BMI (kg/m
2
) 26.4(3.5) 25.9(3.4) 0.272 26.3(3.3) 25.7(3.4) 0.12 26.3(3.5) 25.7(3.3) 0.124 
Waist circ. (cm) 93.8(9.6) 93.2(9.7) 0.612 93.6(9.0) 92.7(9.4) 0.462 93.9(9.4) 92.4(9.4) 0.202 
S-TG (mmol/l) 1.55(0.91) 1.63(1.04) 0.552 1.45(0.66) 1.59(1.05) 0.204 1.59(0.93) 1.55(0.94) 0.742 
S-HDL-C (mmol/l) 1.27(0.28) 1.25(0.31) 0.598 1.26(0.28) 1.25(0.31) 0.756 1.28(0.29) 1.25(0.31) 0.533 
SBP (mmHg) 131(20) 127(19) 0.104 130(19) 124(16) 0.003 130(18) 127(19) 0.156 
DBP (mmHg) 80(11) 78(13) 0.224 80(11) 77(12) 0.013 80(10) 78(13) 0.332 
FG (mmol/l) 4.55(0.77) 4.54(0.84) 0.925 4.49(0.75) 4.51(0.86) 0.797 4.47(0.73) 4.46(0.57) 0.836 
Females MUFA 
  
PUFA 
  
SFA 
  
 
Q1 Q4 p Q1 Q4 p Q1 Q4 p 
BMI (kg/m
2
) 25.1(3.8) 24.9(5.1) 0.732 24.9(3.7) 24.9(5.2) 0.996 25.0(3.7) 24.8(5.0) 0.628 
Waist circ. (cm) 83.6(9.9) 84.8(12.7) 0.381 83.5(9.9) 84.8(13.1) 0.372 83.7(9.9) 84.3(12.3) 0.67 
S-TG (mmol/l) 1.16(0.57) 1.12(0.62) 0.62 1.14(0.51) 1.20(0.72) 0.462 1.13(0.58) 1.15(0.66) 0.816 
S-HDL-C (mmol/l) 1.64(0.45) 1.56(0.41) 0.12 1.67(0.44) 1.56(0.40) 0.036 1.63(0.43) 1.56(0.39) 0.147 
SBP (mmHg) 124(19) 121(17) 0.183 124(18) 121(18) 0.173 121(19) 123(18) 0.575 
DBP (mmHg) 75(11) 73(10) 0.021 76(11) 73(10) 0.034 74(11) 73(11) 0.474 
FG (mmol/l) 4.37(1.09) 4.18(0.70) 0.092 4.29(0.64) 4.20(0.84) 0.357 4.40(1.16) 4.25(1.1) 0.253 
Kcal: kilocalories, TG: triglycerides, HDL: high-density lipoprotein, MetS: metabolic syndrome, SBP: systolic blood pressure, 
DBP: diastolic blood pressure, FG: fasting blood glucose, MUFA: mono-unsaturated fatty acids, PUFA: poly-unsaturated fatty 
acids, SFA: saturated fatty acids, Q: quartile. 
Calculations performed on total energy intake quartiles (kcal/day) and macronutrient quartiles (g/day). 
  Values expressed as mean (s.d.). 
        p-values <0.05 is considered significant. 
       1mono- and disaccharides analysed.        
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Figure 1 
 
 
Figure 2 
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Figure 3 
 
Legend 
Figure 1 
Boxplot illustrating correlation between HDL-cholesterol and quartiles of mono- and 
disaccharides in men. Rank correlation (Spearman’s rho, rs) -0.145 (p<0.01). 
Figure 2 
Boxplot illustrating correlation between systolic blood pressure and quartiles of 
polyunsaturated fatty acids in men. Rank correlation (Spearman’s rho, rs) -0.127 (p<0.01). 
Figure 3 
Boxplot illustrating correlation between diastolic blood pressure and quartiles of 
polyunsaturated fatty acids in men. Rank correlation (Spearman’s rho, rs) -0.131 (p<0.01). 
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Appendix 
 
Table 6a. Correlation coefficients for the association between macronutrients and MetS variables. 
Males CHO Fat Protein Kcal 
BMI (kg/m
2
) 0.03 -0.03 0.047 0.01 
Waist circumference (cm) 0.014 -0.01 0.059 0.02 
S-Triglycerides (mmol/l) 0.104* 0.083 0.07 0.100* 
S-HDL-cholesterol (mmol/l) -0.101* -0.06 -0.063 -0.064 
Systolic blood pressure (mmHg) -0.041 -0.099* -0.064 -0.073 
Diastolic blood pressure (mmHg) -0.047 -0.089* -0.07 -0.074 
Fasting B-glucose (mmol/l) -0.023 -0.02 -0.028 -0.026 
Females CHO Fat Protein Kcal 
BMI (kg/m
2
) 0.024 0.007 0.055 0.021 
Waist circumference (cm) 0.047 0.032 0.08 0.051 
S-Triglycerides (mmol/l) 0.035 0.007 0.001 0.026 
S-HDL-cholesterol (mmol/l) -0.071 -0.06 -0.048 -0.057 
Systolic blood pressure (mmHg) 0.007 -0.02 0.023 -0.002 
Diastolic blood pressure (mmHg) -0.057 -0.08 -0.026 -0.059 
Fasting B-glucose (mmol/l) -0.083* -0.06 -0.018 -0.07 
HDL: high-density lipoprotein, MetS: metabolic syndrome, CHO: Carbohydrates, Kcal: kilocalories, B: 
blood. 
Calculations performed on absolute continuous macronutrients (g/day) and total energy intake (kcal/day). 
All correlations expressed as Pearson correlation coefficient, r. 
 * Correlation is significant at the 0.05 level. 
  ** Correlation is significant at the 0.01 level. 
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Table 6b. Correlation coefficients for the association between sugar, dietary fibre, mono-unsaturated fatty 
acids, poly-unsaturated fatty acids, saturated fatty acids and MetS variables. 
Males Sugar Fibre MUFA PUFA SFA 
BMI (kg/m
2
) 0.111* -0.03 -0.02 -0.061 -0.025 
Waist circumference (cm) 0.08 -0.02 0.003 -0.022 -0.007 
S-Triglycerides (mmol/l) 0.123** 0.112* 0.093* 0.082 0.06 
S-HDL-cholesterol (mmol/l) -0.159** -0.05 -0.063 -0.041 -0.054 
Systolic blood pressure (mmHg) 0.022 -0.02 -0.109* -0.161** -0.053 
Diastolic blood pressure (mmHg) 0.006 -0.03 -0.086 -0.145** -0.057 
Fasting B-glucose (mmol/l) -0.009 -0.03 -0.018 -0.02 -0.021 
Females Sugar Fibre MUFA PUFA SFA 
BMI (kg/m
2
) 0.032 0.028 0.027 0.021 -0.008 
Waist circumference (cm) 0.05 0.059 0.051 0.055 0.012 
S-Triglycerides (mmol/l) 0.034 0.02 0.013 0.043 -0.003 
S-HDL-cholesterol (mmol/l) -0.056 -0.03 -0.072 -0.083* -0.033 
Systolic blood pressure (mmHg) 0.045 -0.02 -0.038 -0.031 -0.006 
Diastolic blood pressure (mmHg) -0.026 -0.07 -0.083* -0.071 -0.064 
Fasting B-glucose (mmol/l) -0.063 -0.06 -0.062 -0.038 -0.052 
HDL: high-density lipoprotein, MetS: metabolic syndrome, MUFA: mono-unsaturated fatty acids, PUFA: poly-
unsaturated fatty acids, SFA: saturated fatty acids, B: blood. 
Calculations performed on absolute continuous macronutrients (g/day). 
 All correlations expressed as Pearson correlation coefficient, r. 
  * Correlation is significant at the 0.05 level. 
   ** Correlation is significant at the 0.01 level. 
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Table 7a. Linear regression continuous macronutrients and MetS variables. 
  Males CHO 
  
Fat 
  
Protein 
  Measure R
2
 β p-value R2 β p-value R2 β p-value 
Waist circ. (cm) 0.801 -0.172 0.002 0.798 0.075 0.213 0.797 0.035 0.473 
S-TG (mmol/l) 0.111 0.069 0.552 0.111 -0.061 0.626 0.116 -0.182 0.074 
S-HDL-C (mmol/l) 0.167 -0.314 0.006 0.154 -0.015 0.902 0.154 0.04 0.688 
SBP (mmHg) 0.209 0.081 0.46 0.209 -0.084 0.479 0.209 -0.074 0.444 
DBP (mmHg) 0.135 0.077 0.503 0.135 -0.037 0.764 0.136 -0.094 0.35 
FG (mmol/l) 0.056 -0.057 0.637 0.057 0.108 0.403 0.056 -0.076 0.469 
          Females CHO 
  
Fat 
  
Protein 
  Measure R
2
 β p-value R2 β p-value R2 β p-value 
Waist circ.(cm) 0.769 -0.029 0.589 0.769 -0.026 0.623 0.769 0.015 0.736 
S-TG (mmol/l) 0.204 0.046 0.653 0.204 -0.05 0.614 0.213 -0.213 0.011
1
 
S-HDL-C (mmol/l) 0.103 -0.206 0.059 0.098 0.059 0.582 0.097 0.008 0.927 
SBP (mmHg) 0.313 -0.078 0.407 0.312 0.065 0.483 0.311 -0.015 0.85 
DBP (mmHg) 0.243 -0.128 0.196 0.241 0.019 0.849 0.24 0.014 0.864 
FG (mmol/l) 0.07 -0.164 0.135 0.068 0.114 0.289 0.072 0.169 0.06 
CHO: carbohydrates, TG: triglycerides, HDL: high-density lipoprotein, SBP: systolic blood pressure, DBP: 
diastolic blood pressure, FG: fasting blood glucose, MetS: metabolic syndrome, β: standardized coefficient, R2: 
adjusted R
2
. 
Calculations performed on continuous macronutrients (g/day). 
   Adjustment made for BMI, age, physical activity (leisure time) and total energy intake (kcal/day). 
p-values <0.05 is considered significant. 
      1 does not meet requirement of normal distribution for residuals. 
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Table 7b. Linear regression total caloric intake, sugar, dietary fibre, mono-unsaturated fatty acids, poly-unsaturated 
fatty acids, saturated fatty acids and MetS variables. 
Males Kcal 
  
Sugar
2
 
  
Fibre 
  Measure R
2
 β p-value R2 β p-value R2 β p-value 
Waist circ. (cm) 0.798 0.016 0.43 0.8 -0.077 0.018 0.797 0.001 0.979 
S-TG (mmol/l) 0.112 0.087 0.042
1
 0.111 0.043 0.53 0.119 0.133 0.032
1
 
S-HDL-C (mmol/l) 0.156 -0.043 0.306 0.169 -0.201 0.003 0.156 -0.069 0.255 
SBP (mmHg) 0.21 -0.034 0.4 0.211 0.093 0.15 0.208 0.016 0.787 
DBP (mmHg) 0.136 -0.047 0.266 0.136 0.069 0.307 0.134 0.014 0.824 
FG (mmol/l) 0.057 -0.005 0.904 0.056 -0.035 0.616 0.056 -0.048 0.451 
Females Kcal 
  
Sugar
2
 
  
Fibre 
  Measure R
2
 β p-value R2 β p-value R2 β p-value 
Waist circ. (cm) 0.769 0.032 0.101 0.769 -0.012 0.729 0.769 0.026 0.353 
S-TG (mmol/l) 0.205 0.026 0.476 0.204 -0.015 0.814 0.203 0.001 0.985 
S-HDL-C (mmol/l) 0.099 -0.04 0.311 0.099 -0.076 0.266 0.098 -0.009 0.874 
SBP (mmHg) 0.313 0.019 0.571 0.312 0.001 0.981 0.314 -0.063 0.193 
DBP (mmHg) 0.242 -0.046 0.198 0.241 -0.042 0.497 0.244 -0.082 0.105 
FG (mmol/l) 0.068 -0.07 0.078 0.067 -0.05 0.465 0.067 -0.039 0.481 
Males MUFA 
 
PUFA 
  
SFA 
  Measure R
2
 β p-value R2 β p-value R2 β p-value 
Waist circ. (cm) 0.798 0.078 0.167 0.8 0.093 0.016 0.797 -0.008 0.854 
S-TG (mmol/l) 0.11 0.018 0.879 0.111 0.053 0.52 0.115 -0.147 0.119 
S-HDL-C (mmol/l) 0.154 -0.03 0.793 0.154 -0.017 0.828 0.154 0.015 0.874 
SBP (mmHg) 0.21 -0.12 0.281 0.221 -0.22 0.004 0.21 0.088 0.327 
DBP (mmHg) 0.134 0.011 0.921 0.144 -0.187 0.02 0.135 0.062 0.505 
FG (mmol/l) 0.058 0.153 0.209 0.058 0.089 0.288 0.056 0.029 0.77 
Females MUFA 
 
PUFA 
  
SFA 
  Measure R
2
 β p-value R2 β p-value R2 β p-value 
Waist circ. (cm) 0.769 -0.007 0.88 0.769 0.034 0.34 0.769 -0.043 0.313 
S-TG (mmol/l) 0.204 -0.022 0.813 0.207 0.1 0.133 0.205 -0.073 0.359 
S-HDL-C (mmol/l) 0.098 0.042 0.672 0.098 -0.031 0.664 0.099 0.071 0.403 
SBP (mmHg) 0.312 0.064 0.45 0.313 0.064 0.298 0.312 0.033 0.653 
DBP (mmHg) 0.241 0.018 0.842 0.241 0.041 0.529 0.241 0.001 0.985 
FG (mmol/l) 0.067 0.051 0.607 0.069 0.092 0.201 0.068 0.082 0.337 
MUFA: mono-unsaturated fatty acids, PUFA: poly-unsaturated fatty acids, SFA: saturated fatty acids, TG: 
triglycerides, HDL: high-density lipoprotein, SBP: systolic blood pressure, DBP: diastolic blood pressure, FG: 
fasting blood glucose, MetS: metabolic syndrome, β: standardized coefficient, R2: adjusted R2. 
Calculations performed on continuous macronutrients (g/day) and total energy intake (kcal/day). 
Adjustment made for BMI, age, physical activity (leisure time) and total energy intake (kcal/day). 
p-values <0.05 is considered significant. 
      1does not meet requirement of normal distribution for residuals. 
2
 mono- and disaccharides analysed. 
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Legend 
Figure 4 
Scatterplot illustrating correlation between triglycerides and mono- and disaccharides in men. 
Pearson’s correlation coefficient (r) 0.123 (p<0.01). 
Figure 5 
Scatterplot illustrating correlation between HDL-cholesterol and mono- and disaccharides in 
men. Pearson’s correlation coefficient (r) -0.159 (p<0.01). 
Figure 6 
Scatterplot illustrating correlation between systolic blood pressure and polyunsaturated fatty 
acids in men. Pearson’s correlation coefficient (r) -0.161 (p<0.01). 
Figure 7 
Scatterplot illustrating correlation between diastolic blood pressure and polyunsaturated fatty 
acids in men. Pearson’s correlation coefficient (r) -0.145 (p<0.01). 
